Abbott Laboratories
NYSE:ABT
Abbott Laboratories
NYSE:ABT
Price:
106.58 USD
1.24%
Updated:
Apr 19, 2024
Abbott Laboratories
Net Income (Common)
Last
Value
3-Years CAGR
5-Years CAGR
|
Abbott Laboratories
Net Income (Common) Peer Comparison
Comparables:
BDX
BSX
EW
SYK
ISRG
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Abbott Laboratories
NYSE:ABT
|
Net Income (Common)
$5.7B
|
CAGR 3-Years
8%
|
CAGR 5-Years
19%
|
CAGR 10-Years
8%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Net Income (Common)
$1.2B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
3%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Net Income (Common)
$1.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Net Income (Common)
$1.4B
|
CAGR 3-Years
19%
|
CAGR 5-Years
14%
|
CAGR 10-Years
14%
|
|
|
Stryker Corp
NYSE:SYK
|
Net Income (Common)
$3.2B
|
CAGR 3-Years
26%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
12%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Net Income (Common)
$1.8B
|
CAGR 3-Years
19%
|
CAGR 5-Years
10%
|
CAGR 10-Years
10%
|
See Also
What is Abbott Laboratories's Net Income (Common)?
Net Income (Common)
5.7B
USD
5.7B
USD
Based on the financial report for Dec 31, 2023, Abbott Laboratories's Net Income (Common) amounts to 5.7B USD.
What is Abbott Laboratories's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
8%
8%
Over the last year, the Net Income (Common) growth was -17%. The average annual Net Income (Common) growth rates for Abbott Laboratories have been 8% over the past three years , 19% over the past five years , and 8% over the past ten years .
You don't have any saved screeners yet
